Atlas Trials

Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer

Clinical trial NCT01025349 · COMPLETED

Trial details

NCT number
NCT01025349
Sponsor
Taipei Medical University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2005-01-01
Primary completion
2009-09-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.